Boston Scientific Corporation
BSXNYSEHealthcareMedical Devices
As of Oct 22, 2026 close
- Market cap
- $67.86B
- P/E (TTM)
- 18.48
- Forward P/E
- 12.75
- Dividend yield
- -
- 52-week range
- $41.39$105.65
- Volume (live)
- -
- Avg. volume (3M)
- 17.66M
Boston Scientific (BSX) Stock Price & Financial Analysis
Boston Scientific Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $44.62 - $46.05 |
|---|---|
| 52-Week High | $105.65 |
| 52-Week Low | $41.39 |
| Open | $44.72 |
| Volume (last close) | 16.39M |
| Average Volume (3M) | 17.66M |
| Revenue (TTM) | 21.00B |
|---|---|
| Net Income (TTM) | 3.67B |
| Free Cash Flow (TTM) | 1.90B |
| EPS (TTM) | $2.46 |
| Profit Margin | 17.48% |
| Operating Margin | 21.92% |
| Return on Equity (ROE) | 14.73% |
| Debt to Equity | 0.50 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 67.86B |
|---|---|
| Shares Outstanding | 1.47B |
| P/E Ratio (TTM) | 18.48 |
| Forward P/E | 12.75 |
| Price to Sales (P/S) | 3.23 |
| Price to Book (P/B) | 2.72 |
| EV/EBITDA | 14.19 |
| 50-Day MA | $45.90 |
|---|---|
| 200-Day MA | $58.61 |
| 1-Year Change | −55.06% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Boston Scientific at a Glance
As of the Oct 22, 2026 close, Boston Scientific (BSX) has a market capitalization of $67.86B. The stock trades at 18.5× trailing earnings, 12.8× forward earnings and 3.2× sales. Over the trailing twelve months it earned $3.67B on revenue of $21.00B (a 17.5% profit margin) and generated $1.90B of free cash flow. Revenue grew 13.5% year over year.
As of its latest reported balance sheet, it holds $539.00M in cash and securities against $12.50B of debt, a net debt position of $11.96B.
Boston Scientific does not currently pay a dividend.
The share price is down 55.1% over the past year. At $46.01 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $41.38 to $105.65, below its 200-day moving average of $58.60.
Based on 28 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $57.43, 24.8% above the Oct 22, 2026 close.
Frequently Asked Questions About Boston Scientific
What is the current stock price for BSX?
As of the Oct 22, 2026 close, BSX stock trades at $46.01. The 52-week range is $41.39–$105.65, with a day range of $44.62–$46.05.
What is the P/E ratio for BSX?
As of the Oct 22, 2026 close, Boston Scientific's trailing twelve-month (TTM) P/E ratio is 18.5, meaning investors pay $18.5 for every $1 of annual earnings. The forward P/E is 12.8, reflecting analyst expectations for future earnings. Boston Scientific operates in the Healthcare sector.
Does BSX pay dividends?
Boston Scientific does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BSX?
Based on ratings from 28 professional analysts over the last 90 days, the consensus for BSX is Buy. The average 12-month price target is $57.43, a 24.8% upside from the Oct 22, 2026 close of $46.01.
What is the market cap of BSX?
As of the Oct 22, 2026 close, Boston Scientific's market capitalization is $67.86B, classifying it as a large-cap company. Boston Scientific operates in the Healthcare sector within the Medical Devices industry.